Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gastroenterology
»
Pankreas
»
Neoplasms
27. May 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Esophagus
Pankreas
Neoplasms
Pancreatitis
Others
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 3010
Articles 1 - 20 / 60189
(68)Ga-FAPI-46 PET/CT Versus (18)F-FDG PET/CT for Pancreatic Cancer: A Feasibility Study.
J Med Imaging Radiat Oncol
Evans N, Perkins E, Firouzmand S, Black T, Coulon Y, Cavallucci D, O'Rourke N, Wong D.
PMID: 42186148 [PubMed - as supplied by publisher]
Clinical profile and hepatocellular cancer treatment patterns in resource limited settings- a cross-sectional observational study at two tertiary referral teaching hospitals, Addis Ababa, Ethiopia.
BMC Gastroenterol
Hassen TJ, Nigussie S, Teshome H, Seife H.
PMID: 42185963 [PubMed - as supplied by publisher]
CR1(+) tumor-associated macrophages orchestrate an immunosuppressive niche in hepatocellular carcinoma: a genetic and multi-omics dissection.
J Transl Med
Wang Z, Wang Z, Ji X, Zhao L, Zheng K, Yu W, Zhang H, Chang H, Liu F.
PMID: 42185899 [PubMed - as supplied by publisher]
Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancer.
J Gastroenterol
Shibuki T, Hoyek C, Ramaker R, Gottam M, Ueno M, Kawamoto Y, Itoh S, Inoue K, Hashimoto T, Fujisawa T, Imai M, Nakamura Y, Bando H, Pirozzi A, Zheng-Lin B, Abidoye O, Eslinger CR, Sonbol MB, Babiker H, Tran N, Morizane C, Strickler JH, Yoshino T, Bekaii-Saab T, Ikeda M.
PMID: 42185502 [PubMed - as supplied by publisher]
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.
Nat Cancer
Perez KJ, Dias Costa A, Jordan A, Karasic TB, Elganainy D, Kim S, Yuan C, Gui DY, Tan R, Hong SC, Wang X, Cristea S, Coleman E, Truitt M, Oh TG, Zheng H, Furniss CS, Brais L, Bird A, Remland J, Gocheva V, Thalappillil JS, Anderson M, Cleary JM, Enzinger A, Giannakis M, Ng K, Rubinson DA, Schlechter B, Surana R, Singh H, Abrams T, Teitelbaum U, Izgur N, Allen E, Winter PS, Raghavan S, Yeh JJ, Von Hoff D, Liddle C, Downes M, Evans RM, O'Dwyer P, Aguirre A, Nowak JA, Wolpin BM.
PMID: 42185478 [PubMed - as supplied by publisher]
Trend of Adjuvant Radiation in Resected Pancreatic Ductal Adenocarcinoma: Evaluation of RTOG 0848 with a Large National Database.
J Gastrointest Cancer
Dickey EM, Blansfield J, Hoffman RL, Jiang JM, Amini N.
PMID: 42184090 [PubMed - indexed for MEDLINE]
Present and future of liver transplantation for cholangiocellular carcinoma: moving toward personalized multiparametric transplantability patterns.
Transpl Int
Cillo U, Furlanetto A, Lanari J, Nieddu E, Rosso E, D'Amico FE, Bassi D, Gringeri E.
PMID: 42183187 [PubMed - indexed for MEDLINE]
Data-driven precision: artificial intelligence redefining immunoradiotherapy in advanced pancreatic cancer.
Front Pharmacol
Liu YW, Men XD, Di BR, Lei YL, Xiang L, Luo YH.
PMID: 42181887 [PubMed]
Case Report: When pancreatic cancer is not cancer: a rare case of pancreatic head paraganglioma with life-threatening delayed pseudoaneurysm bleeding.
Front Surg
Ozcan A, Gunes G, Aydog G, Akkurt G.
PMID: 42181541 [PubMed]
Ferroptosis-related lncRNA signature predicts prognosis and treatment response in colon cancer.
Transl Cancer Res
Wang T, Wang C, Lu Y, Zhong Y, Xue Y, Liu X, Chen E, Lv G.
PMID: 42180976 [PubMed]
Plasma fatty acid associated with risk of gastrointestinal cancer: a prospective cohort study from UK Biobank.
Transl Cancer Res
Song T, Hu S, Sun Y, Wu J, Wu Y, Li X.
PMID: 42180903 [PubMed]
Optimization of temporal phase in multi-phase contrast-enhanced MRI for gross tumor volume determination in pancreatic cancer radiotherapy.
Transl Cancer Res
Meng K, Guo Y, Yin Y, Su Y, Wang L, Wang R, Gong G.
PMID: 42180859 [PubMed]
Effect of polyunsaturated fatty acids supplementation on nutritional status in patients with pancreatic cancer: a systematic review and meta-analysis.
PeerJ
Liu G, Wu C, Yang X, Liu Z, Zhu Y, Yang T, Zhang J, Lin X.
PMID: 42180603 [PubMed - indexed for MEDLINE]
In vitro study of biologically synthesized MgO nanoparticles cytotoxicity in cancer cell lines.
3 Biotech
Shivappa P, Gaddigal AT, Ganeshkar MP, Mirjankar MR, Poojari PB, Huyilagola PV, Irannanavar KM, Irannanavar SV, Kamanavalli CM.
PMID: 42179919 [PubMed]
Beyond a passive coating: The cancer glycocalyx as a dynamic biophysical and immune interface.
Histol Histopathol
Tomita H.
PMID: 42178997 [PubMed - as supplied by publisher]
Adrenocortical Carcinoma in Peutz-Jeghers Syndrome With a Rare STK11 Pathogenic Germline Variant: A Case Report.
Cancer Rep (Hoboken)
Ishida T, Kandori S, Takahashi R, Nitta S, Shiga M, Nagumo Y, Kawahara T, Hoshi A, Negoro H, Mathis BJ, Sugita S, Matsubara D, Ishiguro T, Nakajima T, Nishiyama H.
PMID: 42178247 [PubMed - indexed for MEDLINE]
Diagnostic performance of droplet digital PCR for KRAS mutation analysis in pancreatic cancer cytology specimens.
J Gastroenterol
Umemoto K, Nakahara K, Ohike N, Satta Y, Sekine A, Igarashi Y, Nagata Y, Kubota Y, Takeda H, Horie Y, Arai H, Izawa N, Hiraki H, Norose T, Koike J, Matoba R, Nishizuka S, Tateishi K, Sunakawa Y.
PMID: 42177316 [PubMed - as supplied by publisher]
First-Line Pembrolizumab Plus Chemotherapy for Advanced Biliary Tract Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-966 Study.
Adv Ther
Ren Z, Liang T, Gu S, Gou H, Peng C, Pan Y, Song T, Su H, Cao K, Liang H, Ying J, Geng Z, Yu W, Zhao H, Bai Y, Hao C, Mao Y, Li W, Wang L, Li D, Wang W, Li N, Malhotra U, Qin S.
PMID: 42176183 [PubMed - as supplied by publisher]
Outcomes of Patients With Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab in Real-World Clinical Practice Who Met or Did Not Meet the Inclusion Criteria for the Phase 3 HIMALAYA Trial.
J Gastroenterol Hepatol
Matono T, Tada T, Hiraoka A, Hirooka M, Nakamura Y, Yoshida O, Kariyama K, Nouso K, Tani J, Morishita A, Atsukawa M, Itokawa N, Okubo T, Arai T, Takaguchi K, Tsutsui A, Nagano T, Itobayashi E, Nishimura T, Fukunishi S, Enomoto H, Tsuji K, Tanaka K, Ishikawa T, Tajiri K, Tanaka H, Toyoda H, Koshiyama Y, Ogawa C, Hatanaka T, Kanayama Y, Kakizaki S, Kawata K, Noritake H, Naganuma A, Kosaka H, Matsui K, Kaibori M, Kuroda H, Yata Y, Nishikawa H, Imai M, Aoki T, Ochi H, Tamai H, Okamura J, Komatsu S, Matsuura T, Nakamura S, Ueda Y, Kim SK, Ohama H, Tada F, Fukumoto T, Hiasa Y, Kudo M, Kumada T.
PMID: 42175630 [PubMed - as supplied by publisher]
Cause-specific mortality in a population-level cohort of pancreatic cancer patients following chemotherapy: A SEER-based study.
Medicine (Baltimore)
Gao Z, Bei L, Peng K.
PMID: 42175404 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 60189
Page 1 of 3010
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy